Bahr, A.R. (2025) “Efficacy and Safety of Tislelizumab in Combination with Chemotherapy versus Placebo Plus Chemotherapy in Patients with Advanced Gastric Cancer or Gastroesophageal Junction Cancer: A Systematic Review of Randomized Controlled Trials”, ASIDE Gastroenterology, 1(2), pp. 16–20. doi:10.71079/ASIDE.GI.06052577.